Hidradenitis suppurativa resulting in systemic amyloid a amyloidosis: A case report and review of the literature

Dermatology Online Journal

Volumn 18, Issue 1, 2012, Pages

  Girouard, Sasha D ^a   Falk, Rodney H ^b   Rennke, Helmut G ^b   Merola, Joseph F ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMYLOID A PROTEIN; ANTIBIOTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLINDAMYCIN; CLONAZEPAM; DEXTROPROPOXYPHENE; ERYTHROPOIETIN; INFLIXIMAB; IRON; ISOTRETINOIN; LINEZOLID; OMEPRAZOLE; STEROID; TETRACYCLINE; ZOLPIDEM;

ABLATION THERAPY; ADULT; AMYLOIDOSIS; ANAMNESIS; ANOREXIA; ARTERIAL WALL THICKENING; ARTHRALGIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHILL; DEBRIDEMENT; DIARRHEA; DISEASE DURATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILY HISTORY; FEVER; HEMOLYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LEG EDEMA; LEUKOCYTOSIS; LOW BACK PAIN; LOW LEVEL LASER THERAPY; MALAISE; MALE; NORMOCHROMIC NORMOCYTIC ANEMIA; PHYSICAL EXAMINATION; RECURRENT DISEASE; SKIN ABSCESS; SKIN EXAMINATION; SKIN FISTULA; SKIN GRAFT; SKIN NODULE; SUPPURATIVE HIDRADENITIS; SUPRAVENTRICULAR TACHYCARDIA; WEIGHT REDUCTION; AMYLOID PLAQUE; ECHOGRAPHY; HEART VENTRICLE; KIDNEY; PATHOLOGY; REVIEW;

ADULT; AMYLOIDOSIS; HEART VENTRICLES; HIDRADENITIS SUPPURATIVA; HUMANS; KIDNEY; MALE; PLAQUE, AMYLOID;

EID: 84856437712     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4):539. [PubMed]
2. Yu CC, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol. 1990;122(6):763. [PubMed]
3. Jansen T, Altmeyer P, and Plewig G. Acne inversa (alias hidranenitis suppurativa). JEADV. 2001;15:532-540. [PubMed]
4. Lapins J, Ye W, Nyrén O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol. 2001;137(6):730-4. [PubMed]
5. Mochella SL. Hidradentitis suppurativa, complications resulting in death. JAMA. 1966;198:201-3. [PubMed]
6. Titze J, Schneider M, Krause H, Jacobi J, Stolte M, Linke RP, Rupprecht HD. Diarrhea, nephrotic syndrome and hidradenitis suppurativa: an unusual case. Nephrol Dial Transplant. 2003;18(1):192-4. [PubMed]
7. Montes-Romero JA, Callejas-Rubio JL, Sánchez-Cano D, Gonzalez-Martinez FJ, Navas-Parejo A, Ortego-Centeno, N. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab. Eur J Intern Med. 2008;19(6):e32-3. [PubMed]
8. Dubrey SW, Cha K, Simms RW, Skinner M, Falk RH. Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. Am J Cardiol. 1996;77:313-5. [PubMed]
9. Dinwoodey DL, Skinner M, Maron MS, Davidoff R, Ruberg FL. Light-chain amyloidosis with echocardiographic features of hypertrophic cardiomyopathy. Am J Cardiol. 2008;101: 674-6. [PubMed]
10. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimre JR, Sabin CA, Gillmore JD, Hawkins PN. Natural history and outcome in systemic AA amyloidosis. N Engl J Med.2007;356(23):2361-71. [PubMed]
11. Haslund P, Lee RA, Jemec GB. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors. Acta Derm Venereol. 2009;89(6):595-600. [PubMed]
12. van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol. 2011;164(6):1292-8. [PubMed]
13. Hsiao JL, Antaya RJ, Berger T, Maurer T, Shinkai K, Leslie KS. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review. Arch Dermatol. 2010; 146(11):1265-70. [PubMed]
14. Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore). 1991;70(4):246-56. [PubMed]
15. Chevrel G, Jenvrin C, McGregor B, Miossec P. Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide. Rheumatology (Oxford). 2001;40(7):821-5. [PubMed]
16. Tan SY, Pepys MB, Hawkins PN. Treatment of amyloidosis. Am J Kidney Dis. 1995;26(2):267-85. [PubMed]
17. Ahlmen M, Ahlmen J, Svalander C, Bucht H. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clin Rheumatol. 1987;6(1):27-38. [PubMed]
18. Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum. 1994;37(12):1804-11. [PubMed]
19. Amemori S, Iwakiri R, Endo H, Ootani A, Ogata S, Noda T, Tsunada S, Sakata H, Matzunaga H, Mizuguchi M, Ikeda Y, Fujimoto K. Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review. J Gasteroenterol. 2006;41(5):444-9. [PubMed]
20. Pettersson T, Konttinen YT, Maury CPJ: Treatment strategies for amyloid A amyloidosis. Expert Opinion on Pharmacotherapy. 2008;9(12):2117-2128. [PubMed]
21. Dember LM, Hawkins PN, Hazenberg BP, Gorevic PD, Merlini G, Butrimiene I, Livneh A, Lesnak O, Puéchal X, Lachmann HJ, Obici L, Balshaw R, Garceau D, Hauck W, Skinner M. Eprosidate for AA Amyloidosis Trial Group: Eprodisate for the treatment of renal disease in AA amyloidosis. N Engl J Med. 2007;356:2349-2360. [PubMed]